Aerovate Therapeutics
AVTE
#9234
Rank
$73.33 M
Marketcap
$2.53
Share price
0.40%
Change (1 day)
-90.45%
Change (1 year)

Earnings for Aerovate Therapeutics (AVTE)

Earnings in 2024 (TTM): -$69.58 Million USD

According to Aerovate Therapeutics's latest financial reports the company's current earnings are N/A. , an increase over its 2023 earnings that were of -$75.47 Million USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Aerovate Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 -$69.58 Million-7.81%
2023 -$75.47 Million46.57%
2022 -$51.49 Million124.24%
2021 -$22.96 Million138.89%
2020 -$9.62 Million